Tokola H, Salo K, Vuolteenaho O, Ruskoaho H
Department of Pharmacology and Toxicology, University of Oulu, Finland.
Eur J Pharmacol. 1994 Apr 15;267(2):195-206. doi: 10.1016/0922-4106(94)90171-6.
We examined the mechanisms involved in the activation of atrial natriuretic peptide (ANP) gene expression and secretion in response to acidic fibroblast growth factor (aFGF) by studying the effects of staurosporine, a protein kinase C inhibitor, and 12-O-tetradecanoyl phorbol 13-acetate (TPA), an activator of protein kinase C, on basal and AFGF-induced ANP messenger RNA (mRNA) and immunoreactive ANP (IR-ANP) levels in cultured neonatal rat cardiac myocytes. Acidic FGF caused a dose- and time-dependent increase in IR-ANP and immunoreactive N-terminal fragment of proANP (IR-NT-proANP) release into the culture medium from ventricular but not from atrial myocytes. In ventricular cells, 50 ng/ml aFGF for 24 or 48 h resulted in a 70% or 181% increase, respectively, in the accumulation of IR-ANP into the culture medium. Acidic FGF also stimulated ANP gene expression significantly; after 48 h of incubation, the ANP mRNA levels of aFGF-treated ventricular myocytes were 205% (P < 0.001) higher than those of control cells. Staurosporine alone at concentration of 10 nM significantly decreased the basal IR-ANP and IR-NT-proANP secretion, and inhibited the aFGF-induced increase in ANP mRNA and IR-ANP levels in ventricular myocytes. TPA (100 nM) alone significantly stimulated ANP gene expression and secretion but these effects were not augmented by combining aFGF with TPA. High performance liquid chromatographical analysis showed that atrial and ventricular myocytes maintained in serum-free medium were capable of secreting processed, ANP99-126 sized material, and that aFGF did not alter the processing of ANP in ventricular cultures. These results demonstrate that aFGF is a potent stimulator of ANP gene expression and secretion in cultured neonatal rat ventricular but not in atrial cells. The observations that (a) staurosporine completely abolished the effects of aFGF on ANP gene expression and release and (b) ANP secretory and gene expression inducing effects of phorbol ester were not augmented by aFGF, suggest an important role of protein kinase C in mediating aFGF-induced ANP gene expression and secretion.
我们通过研究蛋白激酶C抑制剂星形孢菌素和蛋白激酶C激活剂12 - O -十四酰佛波醇13 -乙酸酯(TPA)对培养的新生大鼠心肌细胞中基础和酸性成纤维细胞生长因子(aFGF)诱导的心房利钠肽(ANP)信使核糖核酸(mRNA)及免疫反应性ANP(IR - ANP)水平的影响,来探究aFGF激活ANP基因表达和分泌所涉及的机制。酸性FGF导致IR - ANP和前ANP免疫反应性N端片段(IR - NT - proANP)从心室而非心房肌细胞释放到培养基中的量呈剂量和时间依赖性增加。在心室细胞中,50 ng/ml aFGF作用24小时或48小时,分别导致培养基中IR - ANP积累量增加70%或181%。酸性FGF还显著刺激ANP基因表达;孵育48小时后,aFGF处理的心室肌细胞的ANP mRNA水平比对照细胞高205%(P < 0.001)。单独使用浓度为10 nM的星形孢菌素可显著降低基础IR - ANP和IR - NT - proANP分泌,并抑制aFGF诱导的心室肌细胞中ANP mRNA和IR - ANP水平的增加。单独使用TPA(100 nM)可显著刺激ANP基因表达和分泌,但aFGF与TPA联合使用并未增强这些效应。高效液相色谱分析表明,在无血清培养基中培养的心房和心室肌细胞能够分泌经加工的、大小为ANP99 - 126的物质,且aFGF不会改变心室培养物中ANP的加工过程。这些结果表明,aFGF是培养的新生大鼠心室而非心房细胞中ANP基因表达和分泌的有效刺激剂。(a)星形孢菌素完全消除了aFGF对ANP基因表达和释放的影响以及(b)佛波酯的ANP分泌和基因表达诱导作用未被aFGF增强,这些观察结果表明蛋白激酶C在介导aFGF诱导的ANP基因表达和分泌中起重要作用。